Evidence map›Paper›PMID 34845159›Full record

ReviewCurrent opinion in endocrinology, diabetes, and obesity2022

Continuous glucose monitoring in the hospital: an update in the era of COVID-19.

Chikara Gothong, Lakshmi G Singh, Medha Satyarengga, Elias K Spanakis

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Current opinion in endocrinology, diabetes, and obesity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06473480 (Continuous GLUCOse Monitoring System With a SENSor Compared to Fingerstick Glucose Monitoring in Surgical Wards), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06473480 narecruitingnot on this mapstarted 2024, after this paper: background citation

Continuous GLUCOse Monitoring System With a SENSor Compared to Fingerstick Glucose Monitoring in Surgical Wards (GLUCOSENS)

TypeinterventionalSponsorOdense University HospitalRan2024 to 2025Enrolled329ConditionsDiabetes Mellitus, Hypoglycemia (Diabetic), Hypoglycemia Night, HyperglycemiaArmsAbbott FreeStyle Libre System 2 Plus, Abbott Freestyle Libre Pro
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Postprandial Glucose: A Variable in Continuum.Clinical medicine insights. Endocrinology and diabetes · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Chikara GothongDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine.
Lakshmi G SinghDivision of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore.
Medha SatyarenggaCenter for Diabetes and Endocrinology, University of Maryland Shore Regional Health, Easton, Maryland, USA.
Elias K SpanakisDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine.
Veterans Health Administration · USRegional Health · USUniversity of Maryland, Baltimore · US

Funding

Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans with DM2 at Higher Risk for HypoglycemiaI01CX001825 · VA · BALTIMORE VA MEDICAL CENTER · PI SPANAKIS, ILIAS · 2018 to 2023
–
CSRD VA I01 CX001825
6 · The paper itself

Abstract

purpose of reviewContinuous glucose monitoring (CGM) systems are Food and Drug Administration approved devices for the ambulatory setting; however, they remain investigational systems for inpatient use. This review summarizes the most recent and relevant literature on the use of continuous glucose monitoring in the hospital setting. RECENT

findingsCGM provides real-time glucose data that enable healthcare professionals to make proactive and timelier clinical decisions with regards to diabetes management. CGM devices appear to be safe and accurate systems for glucose monitoring in the hospital setting. Real-time CGM systems and glucose telemetry can decrease hypoglycemia and reduce hyperglycemia in hospitalized patients with diabetes. Remote glucose monitoring decreases the need of frequent Point-of-care checks and personal protective equipment use while also mitigating staff exposure risk which is timely in the advent of the COVID-19 pandemic. Although most nursing staff have limited exposure and training on CGM technology, early studies show that CGM use in the hospital is well received by nurses. SUMMARY: Given the evidence in the current literature regarding CGM use in the hospital, CGM devices may be incorporated in the inpatient setting.

Indexed as

COVID-19Diabetes Mellitus, Type 1Blood GlucoseBlood Glucose Self-MonitoringHospitalsHumansPandemicsSARS-CoV-2Blood Glucose

Identifiers

PMID34845159
PMCPMC8711300
OpenAlexW3216149055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.